Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyridones | 2 | 2017 | 35 | 1.000 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2017 | 100 | 0.920 |
Why?
|
| Critical Illness | 5 | 2016 | 331 | 0.910 |
Why?
|
| Hypnotics and Sedatives | 4 | 2016 | 71 | 0.860 |
Why?
|
| Analgesics | 2 | 2016 | 100 | 0.730 |
Why?
|
| Liver Diseases | 2 | 2016 | 135 | 0.700 |
Why?
|
| Kidney Diseases | 2 | 2016 | 157 | 0.700 |
Why?
|
| Pregnenediones | 1 | 2020 | 3 | 0.700 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2020 | 42 | 0.650 |
Why?
|
| Glucocorticoids | 1 | 2020 | 167 | 0.620 |
Why?
|
| Indoles | 1 | 2017 | 96 | 0.570 |
Why?
|
| Dabigatran | 1 | 2016 | 23 | 0.540 |
Why?
|
| Antithrombins | 1 | 2016 | 16 | 0.530 |
Why?
|
| Blood Coagulation | 1 | 2016 | 50 | 0.520 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 216 | 0.470 |
Why?
|
| Hemorrhage | 1 | 2016 | 276 | 0.470 |
Why?
|
| Nutrition Therapy | 1 | 2014 | 7 | 0.470 |
Why?
|
| Parenteral Nutrition | 1 | 2014 | 21 | 0.460 |
Why?
|
| Critical Care | 5 | 2016 | 404 | 0.390 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 202 | 0.370 |
Why?
|
| Liver Failure | 1 | 2010 | 16 | 0.360 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2008 | 4 | 0.320 |
Why?
|
| Propylene Glycol | 1 | 2008 | 3 | 0.320 |
Why?
|
| Acidosis, Lactic | 1 | 2008 | 11 | 0.310 |
Why?
|
| Antithrombin III | 1 | 2004 | 14 | 0.240 |
Why?
|
| Enoxaparin | 1 | 2004 | 15 | 0.240 |
Why?
|
| Burns | 1 | 2004 | 43 | 0.230 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 104 | 0.220 |
Why?
|
| Liver Function Tests | 2 | 2016 | 36 | 0.200 |
Why?
|
| Kidney Function Tests | 2 | 2016 | 34 | 0.200 |
Why?
|
| Humans | 15 | 2020 | 58855 | 0.190 |
Why?
|
| Drug Monitoring | 2 | 2016 | 98 | 0.190 |
Why?
|
| Treatment Outcome | 3 | 2020 | 5099 | 0.170 |
Why?
|
| Medical Order Entry Systems | 1 | 2020 | 45 | 0.170 |
Why?
|
| Electronic Mail | 1 | 2020 | 45 | 0.170 |
Why?
|
| Reminder Systems | 1 | 2020 | 71 | 0.160 |
Why?
|
| Anticoagulants | 2 | 2020 | 485 | 0.160 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 168 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 119 | 0.150 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 138 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 170 | 0.150 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2017 | 23 | 0.150 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2017 | 33 | 0.150 |
Why?
|
| Diarrhea | 1 | 2017 | 72 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2020 | 346 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 168 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 662 | 0.130 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 432 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 444 | 0.130 |
Why?
|
| Pharmacists | 2 | 2020 | 123 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 708 | 0.120 |
Why?
|
| Carnitine | 1 | 2014 | 21 | 0.120 |
Why?
|
| Critical Care Nursing | 1 | 2014 | 17 | 0.110 |
Why?
|
| Selenium | 1 | 2014 | 25 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 435 | 0.110 |
Why?
|
| Quality of Life | 1 | 2020 | 1102 | 0.100 |
Why?
|
| Hospitalization | 1 | 2020 | 1270 | 0.100 |
Why?
|
| Pharmacokinetics | 1 | 2012 | 7 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1013 | 0.100 |
Why?
|
| Lipids | 1 | 2014 | 302 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 794 | 0.100 |
Why?
|
| Stroke | 1 | 2020 | 1135 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 2 | 2012 | 41 | 0.090 |
Why?
|
| Intestinal Absorption | 2 | 2012 | 28 | 0.090 |
Why?
|
| Sepsis | 1 | 2014 | 278 | 0.090 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 22 | 0.090 |
Why?
|
| Insulin | 1 | 2014 | 682 | 0.090 |
Why?
|
| Anesthetics, Intravenous | 1 | 2009 | 27 | 0.090 |
Why?
|
| Propofol | 1 | 2009 | 27 | 0.080 |
Why?
|
| Biological Availability | 2 | 2012 | 189 | 0.080 |
Why?
|
| Intensive Care Units | 2 | 2010 | 445 | 0.080 |
Why?
|
| Pentobarbital | 1 | 2008 | 4 | 0.080 |
Why?
|
| Status Epilepticus | 1 | 2008 | 22 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 170 | 0.080 |
Why?
|
| Incidence | 1 | 2009 | 1226 | 0.070 |
Why?
|
| Nursing Assessment | 1 | 2005 | 40 | 0.060 |
Why?
|
| Half-Life | 1 | 2005 | 70 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 67 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 280 | 0.060 |
Why?
|
| Female | 6 | 2020 | 30564 | 0.060 |
Why?
|
| Telemedicine | 1 | 2010 | 327 | 0.060 |
Why?
|
| Middle Aged | 4 | 2020 | 16127 | 0.050 |
Why?
|
| Male | 5 | 2020 | 27275 | 0.050 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 137 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 343 | 0.040 |
Why?
|
| Home Care Services | 1 | 2020 | 101 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2020 | 219 | 0.040 |
Why?
|
| Adult | 3 | 2020 | 15602 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 439 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2020 | 295 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 477 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 554 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 737 | 0.030 |
Why?
|
| Massachusetts | 1 | 2020 | 2076 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 3544 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 127 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2012 | 150 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 13215 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 4975 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 173 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 142 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 772 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1542 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2010 | 294 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 312 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 285 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 701 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2009 | 3074 | 0.010 |
Why?
|
| Heart Failure | 1 | 2009 | 859 | 0.010 |
Why?
|